The Discounted Cash Flow (DCF) valuation of Champions Oncology Inc (CSBR) is (18.30) USD. With the latest stock price at 6.47 USD, the upside of Champions Oncology Inc based on DCF is -382.8%.
Based on the latest price of 6.47 USD and our DCF valuation, Champions Oncology Inc (CSBR) is a sell. selling CSBR stocks now will result in a potential gain of 382.8%.
Note: valuation result may not be accurate due to the company's negative cashflows.
| Range | Selected | |
| WACC / Discount Rate | 5.1% - 6.1% | 5.6% |
| Long-term Growth Rate | 3.0% - 4.8% | 3.9% |
| Fair Price | (119.33) - (10.18) | (18.30) |
| Upside | -1944.3% - -257.4% | -382.8% |